Press Releases Year None2019201820172016 Gamida Cell Announces Immune Reconstitution Data from Completed Phase 1/2 Clinical Study of NiCord® Presented at 2019 TCT Annual Meeting February 23, 2019 PDF Version View HTML Gamida Cell Presents New Data from Ongoing Phase 1 Study of NAM-NK and Initial Data from Phase 1/2 Study of NiCord® in Severe Aplastic Anemia at 2019 TCT Annual Meeting February 21, 2019 PDF Version View HTML Gamida Cell Announces Agreement with Editas Medicine to Evaluate Use of CRISPR Genome Editing Technology in NAM-NK Cells February 19, 2019 PDF Version View HTML Gamida Cell to Host Conference Call and Webcast to Review Data from NAM-NK and NiCord® Programs Being Presented at 2019 TCT Annual Meeting February 14, 2019 PDF Version View HTML Gamida Cell Announces Data from NAM-NK and NiCord® Programs to Be Presented at 2019 TCT Annual Meeting January 24, 2019 PDF Version View HTML Gamida Cell and Be The Match BioTherapies® Announce Strategic Collaboration January 22, 2019 PDF Version View HTML Gamida Cell Announces 2019 Goals and Provides Company Update January 7, 2019 PDF Version View HTML Pagination First page « first Previous page ‹ previous Page 1 Current page 2 Displaying 11 - 17 of 17
